Skip to search formSkip to main contentSkip to account menu

lornoxicam

Known as: Lornoxicamum, xefocam, Chlortenoxicam 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Clinical utility of lornoxicam in oral therapy is primarily restricted by the low solubility and gastric adverse effects. This… 
Highly Cited
2015
Highly Cited
2015
Abstract Oro-dental diseases are generally associated with pain that is controlled using oral tablets containing NSAIDs… 
Highly Cited
2015
Highly Cited
2015
Abstract Solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and nanoemulsion (NE) of lornoxicam (LRX) were… 
2015
2015
Abstract The present work was performed aiming to develop a new solid self-emulsifying system (SMEDDS) for poorly water-soluble… 
Highly Cited
2014
Highly Cited
2014
The current study was designed to develop a topical gel formulation for improved skin penetration of lornoxicam (LOR) for… 
Highly Cited
2011
Highly Cited
2011
Genetic polymorphisms in many genes related to drug absorption, distribution, metabolism and excretion (ADME genes) contribute to… 
Highly Cited
2000
Highly Cited
2000
Lornoxicam is a member of the oxicam group of nonsteroidal antiinflammatory drugs (NSAIDs). Oxicams have potent antiinflammatory… 
Highly Cited
1999
Highly Cited
1999
This randomized double‐blind study compared the analgesic efficacy and tolerability of intramuscular lornoxicam and tramadol in… 
Review
1998
Review
1998
SummaryLornoxicam (chlorotenoxicam) is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class. Unlike other oxicams… 
Highly Cited
1996
Highly Cited
1996
OBJECTIVE To compare the efficacy and tolerability of lornoxicam and diclofenac in the treatment of patients with osteoarthritis…